Quantcast

Latest kidney transplant Stories

2011-07-20 07:03:35

(Ivanhoe Newswire) "“ Avoiding kidney mismatching is beneficial in pediatric kidney transplant patients, however, the likelihood of finding a matching donor must be considered against the wait time for a possible donation, according to this study. "Although avoiding HLA [human leukocyte antigen; cell surface antigens that regulate host cell responses to transplanted cells] antigen mismatching has been shown to benefit long-term graft survival, it has raised concerns about disadvantaging...

2011-06-15 16:13:00

SILVER SPRING, Md., June 15, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Nulojix (belatacept) to prevent acute rejection in adult patients who have had a kidney transplant. The drug is approved for use with other immunosuppressants (medications that suppress the immune system) -- specifically basiliximab, mycophenolate mofetil, and corticosteroids. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Nulojix is a type of drug called a...

2011-06-13 07:57:00

LAWRENCE, Mass., June 13, 2011 /PRNewswire/ -- NxStage ® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that patient advocate Harvey Wells has successfully undergone a kidney transplant, bringing to a rewarding close his four years of frequent home hemodialysis with the NxStage® System One(TM). (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) Wells, 59, of Euless, Texas has been a...

2011-05-10 15:10:43

Implications for kidney transplant recipients and kidney donors A new study by researchers at Wake Forest Baptist Medical Center sheds light on what causes certain kidneys to do better than others after being transplanted, providing doctors with an easy way to screen for donor kidneys that have the best chance of survival. "It's been long observed that kidneys taken from some black donors just don't last as long as those taken from non-black donors, and the reason for that has not been...

2011-04-07 22:32:52

A new study from Mayo Clinic (http://www.mayoclinic.com/), the largest long-term study of kidney transplant recipients published to date, demonstrates that progressive damage to kidney transplants may be less common and less severe than previously reported. The study, involving 797 patients transplanted between 1998 and 2004 and followed for at least five years, shows that 87 percent of patients have mild or no signs of progressive scar damage to the transplanted organ when biopsied at one...

2011-03-17 21:13:02

U-M researcher supports proposed concepts for changing how kidneys are allocated, in commentary published in New England Journal of Medicine Providing kidney transplants to patients with the best probability of longer survival would reduce repeat transplant operations and improve life span after kidney transplant, says a U-M researcher in a commentary published in the New England Journal of Medicine March 16. Alan B. Leichtman, M.D., professor of Internal Medicine at U-M and his co-authors...

2011-02-22 02:50:48

Sharing printed educational materials about the risk of squamous cell carcinoma with kidney transplant recipients appeared to be effective at increasing skin self-examination and encouraging follow-up with a dermatologist to determine risk of cancer, according to a report posted online today that will appear in the June issue of Archives of Dermatology, one of the JAMA/Archives journals. "In the United States, an estimated 100,000 living kidney transplant recipients are at risk to develop...

2011-02-11 14:29:00

Test monitors level of a drug that helps prevent kidney rejection SILVER SPRING, Md., Feb. 11, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that it has cleared a test to help manage potential organ rejection in kidney transplant patients. The test, called QMS Everolimus Immunoassay, monitors the blood level of everolimus, a drug that helps prevent rejection in kidney transplants. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)...

2011-01-14 08:55:59

Survival rates similar for home and hospital dialysis, but few choose home version despite flexibility, cost savings Patients who must return to dialysis after a kidney transplant failure survive just as well on home dialysis as hospital dialysis, but few choose that option, according to new research by Dr. Jeffrey Perl, a nephrologist at St. Michael's Hospital. Despite medical advances, transplanted kidneys don't last a lifetime and an increasing number of patients return to dialysis. These...

2011-01-14 08:45:40

Dialysis at home is just as effective as in the clinic Patients returning to dialysis after kidney transplant failure present unique challenges compared with other dialysis patients: they have been exposed to very powerful immunosuppressive medications and have been on dialysis for a longer period of time than other dialysis patients. This puts them at particularly high risk for various complications and death. According to a study appearing in an upcoming issue of the Clinical Journal of the...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related